multiple sclerosis	is an	autoimmune disease
multiple sclerosis	is a	demyelinating disease
multiple sclerosis	is a	chronic disease
multiple sclerosis	affects	central nervous system
central nervous system	comprises	brain and spinal cord
brain	is a	component of central nervous system
spinal cord	is a	component of central nervous system
optic nerve	can be affected by	multiple sclerosis
relapsing-remitting MS	is a	MS subtype
primary progressive MS	is a	MS subtype
secondary progressive MS	is a	MS subtype
EDSS	is a	disability scale
fatigue	is a	common MS symptom
numbness	is a	MS symptom
paresthesia	is a	MS symptom
weakness	is a	MS symptom
spasticity	is a	MS symptom
ataxia	is a	MS symptom
optic neuritis	is a	MS symptom
cognitive impairment	is a	MS symptom
depression	is a	MS comorbidity
anxiety	is a	MS comorbidity
urinary incontinence	is a	MS symptom
bowel dysfunction	is a	MS symptom
fatigue	worsens	quality of life
MRI	detects	demyelinating lesions
MRI	shows	lesion burden
gadolinium-enhancing lesion	indicates	active inflammation
oligoclonal bands	are a	CSF marker for multiple sclerosis
T2 lesion	indicates	tissue damage
lesion burden	correlates with	disability
EDSS	correlates with	disability level
CSF	contains	oligoclonal bands
glatiramer acetate	is a	disease-modifying therapy
interferon beta	is a	disease-modifying therapy
dimethyl fumarate	is a	disease-modifying therapy
fingolimod	is a	disease-modifying therapy
natalizumab	is a	disease-modifying therapy
ocrelizumab	is a	disease-modifying therapy
siponimod	is a	disease-modifying therapy
alemtuzumab	is a	disease-modifying therapy
methylprednisolone	is a	corticosteroid
high-dose corticosteroids	are a	relapse treatment
plasma exchange	is a	therapy for MS relapse
prednisone	is a	corticosteroid
baclofen	is a	muscle relaxant
tizanidine	is a	muscle relaxant
gabapentin	is a	neuropathic pain agent
amitriptyline	is a	neuropathic pain agent
physical therapy	is a	supportive therapy for multiple sclerosis
occupational therapy	is a	supportive therapy for multiple sclerosis
rehabilitation	is a	supportive care for MS
spasticity	treated with	baclofen
spasticity	treated with	tizanidine
urinary catheterization	is a	management for urinary incontinence
bladder dysfunction	is a	MS symptom
depression	affects	treatment adherence
anxiety	affects	treatment adherence
smoking	increases	MS risk
vitamin D deficiency	increases	MS risk
obesity	increases	MS progression
age at onset	influences	MS phenotype
female sex	is associated with	higher MS risk
pregnancy	reduces	relapse frequency during pregnancy
postpartum period	increases	relapse risk after delivery
autologous hematopoietic stem cell transplantation	is a	potential treatment for MS
visual impairment	is a	MS symptom
brain atrophy	is a	MS biomarker
radiologically isolated syndrome	is a	MS precursor
optic pathway	is affected in	MS
relapse	triggers	steroid therapy
steroid therapy	is a	relapse treatment
demyelination	is a	pathological process of MS
axon loss	occurs in	MS lesions
inflammation	drives	demyelination in MS
oligodendrocyte precursor cells	contribute to	remyelination in MS
neurodegeneration	is a	component of MS pathology
blood-brain barrier disruption	is a	MS feature
inflammatory cells	participate in	MS pathology
myelin	is a	substrate damaged in MS
remyelination	occurs in	MS
disease-modifying therapy	reduces	relapse rate
early treatment	improves	prognosis
disability progression	correlates with	lesion burden
brain atrophy	correlates with	cognitive decline
visual evoked potential	is used for	optic pathway assessment
radiologic surveillance	monitors	disease activity
contrast enhancement	reflects	active disease
radiologically isolated syndrome	is a	MS precursor
evoked potentials	are used for	MS evaluation
MRI surveillance	monitors	disease activity
pediatric multiple sclerosis	occurs	in children
children	require	MS-specific therapy adjustments
therapy adherence	affects	MS outcomes
lifestyle modification	improves	disease management
exercise therapy	improves	mobility
nutrition	supports	MS management
sleep disturbance	co-occurs with	MS
infection risk	increases	with corticosteroid use
vaccination	is recommended during	MS therapy
patient education	improves	medication adherence
